Breaking News, Promotions & Moves

Gilead Sciences

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Norbert W. Bischofberger, Ph.D. has been named executive vice president, R&D and chief scientific officer and John F. Milligan, Ph.D. has been named chief operating officer, Gilead Sciences, Inc. Dr. Bischofberger joined the company in 1990 from Genentech, where he held roles of increasing responsibility within R&D, and was most recently appointed executive vice president, R&D in 2000. In his new role, Dr. Bischofberger will oversee all aspects of Gilead’s R&D efforts...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters